“Myxovirus Resistance, Osteopontin and Suppressor of Cytokine Signaling 3 Polymorphisms Predict Hepatitis C Virus Therapy Response in an Admixed Patient Population: Comparison With IL28B”. Clinics, vol. 68, no. 10, Oct. 2013, pp. 1325-32, https://doi.org/10.1590/clin.v68i10.77009.